Fatigue Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Fatigue – Drugs In Development, 2022, provides an overview of the Fatigue (Central Nervous System) pipeline landscape.

Fatigue also referred to as tiredness, exhaustion, lethargy, listlessness, and describes a physical and/or mental state of being tired and weak. Signs and symptoms include aching or sore muscles, painful lymph nodes, chronic (long-term) tiredness, dizziness, headache, irritability and loss of appetite.

Report Highlights

Global Markets Direct’s Pharmaceutical and Healthcare latest pipeline guide Fatigue – Drugs In Development, 2022, provides comprehensive information on the therapeutics under development for Fatigue (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Fatigue (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Fatigue and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I, Preclinical and Unknown stages are 4, 2, 3 and 2 respectively.

Fatigue Drugs in Development_GMDHC22010IDB

Fatigue (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

– The pipeline guide provides a snapshot of the global therapeutic landscape of Fatigue (Central Nervous System).

– The pipeline guide reviews pipeline therapeutics for Fatigue (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.

– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

– The pipeline guide reviews key companies involved in Fatigue (Central Nervous System) therapeutics and enlists all their major and minor projects.

– The pipeline guide evaluates Fatigue (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

– The pipeline guide reviews latest news related to pipeline therapeutics for Fatigue (Central Nervous System)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Fatigue (Central Nervous System).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Fatigue (Central Nervous System) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Companies mentioned

Aoxing Pharmaceutical Company Inc

Bioprojet SCR

Contero Therapeutics

Dompe Farmaceutici SpA

Helsinn Group

K-Pax Pharmaceuticals Inc

MetVital Inc

Primetime Life Sciences LLC

Resolys Bio Inc

Sunny Pharmtech Inc

Table of Contents

Table of Contents

List of Tables

List of Figures

Introduction

Global Markets Direct Report Coverage

Fatigue - Overview

Fatigue - Therapeutics Development

Pipeline Overview

Pipeline by Companies

Products under Development by Companies

Fatigue - Therapeutics Assessment

Assessment by Target

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Fatigue - Companies Involved in Therapeutics Development

Aoxing Pharmaceutical Company Inc

Bioprojet SCR

Contero Therapeutics

Dompe Farmaceutici SpA

Helsinn Group

K-Pax Pharmaceuticals Inc

MetVital Inc

Primetime Life Sciences LLC

Resolys Bio Inc

Sunny Pharmtech Inc

Fatigue - Drug Profiles

anamorelin hydrochloride - Drug Profile

Product Description

Mechanism Of Action

History of Events

Anhydrous enol oxaloacetate - Drug Profile

Product Description

Mechanism Of Action

History of Events

Biologic for Chronic Pain and Fatigue - Drug Profile

Product Description

Mechanism Of Action

BP-1.3656B - Drug Profile

Product Description

Mechanism Of Action

caffeine - Drug Profile

Product Description

Mechanism Of Action

CTDP-001 - Drug Profile

Product Description

Mechanism Of Action

History of Events

KPAX-002 - Drug Profile

Product Description

Mechanism Of Action

History of Events

phenylbutyrate - Drug Profile

Product Description

Mechanism Of Action

pitolisant hydrochloride - Drug Profile

Product Description

Mechanism Of Action

History of Events

PLS-4 - Drug Profile

Product Description

Mechanism Of Action

reparixin - Drug Profile

Product Description

Mechanism Of Action

History of Events

Fatigue - Dormant Projects

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

List of Tables

Number of Products under Development for Fatigue, 2022

Number of Products under Development by Companies, 2022

Products under Development by Companies, 2022

Number of Products by Stage and Target, 2022

Number of Products by Stage and Mechanism of Action, 2022

Number of Products by Stage and Route of Administration, 2022

Number of Products by Stage and Molecule Type, 2022

Fatigue – Pipeline by Aoxing Pharmaceutical Company Inc, 2022

Fatigue – Pipeline by Bioprojet SCR, 2022

Fatigue – Pipeline by Contero Therapeutics, 2022

Fatigue – Pipeline by Dompe Farmaceutici SpA, 2022

Fatigue – Pipeline by Helsinn Group, 2022

Fatigue – Pipeline by K-Pax Pharmaceuticals Inc, 2022

Fatigue – Pipeline by MetVital Inc, 2022

Fatigue – Pipeline by Primetime Life Sciences LLC, 2022

Fatigue – Pipeline by Resolys Bio Inc, 2022

Fatigue – Pipeline by Sunny Pharmtech Inc, 2022

Fatigue – Dormant Projects, 2022

List of Figures

List of Figures

Number of Products under Development for Fatigue, 2022

Number of Products under Development by Companies, 2022

Number of Products by Targets, 2022

Number of Products by Stage and Targets, 2022

Number of Products by Top 10 Mechanism of Actions, 2022

Number of Products by Stage and Top 10 Mechanism of Actions, 2022

Number of Products by Routes of Administration, 2022

Number of Products by Stage and Routes of Administration, 2022

Number of Products by Molecule Types, 2022

Number of Products by Stage and Molecule Types, 2022

    Pricing

Discounts available for multiple purchases.

reportstore@globalmarketsdirect.com
+44 20 7947 2960

Saved reports